72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study - Concepedia

Concepedia

Publication | Open Access

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study

DOI Full Paper Access

50

Citations

15

References

2022

Year

Thokozile R. Malaba, Irene Nakatudde, Kenneth Kintu, Angela Colbers, Tao Chen, Helen Reynolds, Lucy Read, Jim Read, Lee-Ann Stemmet, Megan Mrubata,

Abstract

Unitaid.

References

	Year	Citations

Page 1